Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66
Nutrients · 29.12.2023 · 16 (1) · 126
DOI: 10.3390/nu16010126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 29.12.2023. Verfasst von Jui-Fen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan. Hauptthemen laut MEDLINE: Lacticaseibacillus paracasei, Lactiplantibacillus plantarum, Probiotics. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Glac Biotech Co., Ltd..
Abstract (Originalsprache)
Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus paracasei ET-66, Lactobacillus plantarum LPL28, and Lactobacillus acidophilus TYCA06, isolated from healthy breast milk, miso, and the healthy human gut, were assessed for safety in this study. BLI-02, LPL28, TYCA06, and ET-66 exhibited no antibiotic resistance and mutagenic activity in the Ames test at the highest dosage (5000 μg/plate). No genotoxicity was observed in micronucleus and chromosomal aberration assays in rodent spermatogonia at the maximum dosage of 10 g/kg body weight (BW). No acute and sub-chronic toxicity occurred in mice and rats at the maximum tested dosage of 10 g/kg BW and 1.5 g/kg BW, respectively. The lyophilized powder of these strains survived a low pH and high bile salt environment, adhering strongly to Caco-2 cells. Unique antimicrobial activities were noted in these strains, with BLI-02 demonstrating the best growth inhibition against Vibrio parahaemolyticus, LPL28 exhibiting the best growth inhibition against Helicobacter pylori, and ET-66 showing the best growth inhibition against Aggregatibacter actinomycetemcomitans. Based on the present study, the lyophilized powder of these four strains appears to be a safe probiotic supplement at tested dosages. It should be applicable for clinical or healthcare applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan.
- Functional Investigation Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan.
- Process Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan.
ORCID-Profile: Yi-Wei Kuo, Yen-Yu Huang, Yu-Chieh Hsu
Förderung
- Glac Biotech Co., Ltd.
Zitieren
APA
Chen, J. F., Hsia, K. C., Kuo, Y. W., Chen, S. H., Huang, Y. Y., Li, C. M., Hsu, Y. C., Tsai, S. Y., & Ho, H. H. (2023). Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66. Nutrients, 16(1), 126. https://doi.org/10.3390/nu16010126
Vancouver
Chen JF, Hsia KC, Kuo YW, Chen SH, Huang YY, Li CM, et al. Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66. Nutrients. 2023;16(1):126. doi:10.3390/nu16010126
BibTeX
@article{Chen2023,
author = {Chen, Jui-Fen and Hsia, Ko-Chiang and Kuo, Yi-Wei and Chen, Shu-Hui and Huang, Yen-Yu and Li, Ching-Min and Hsu, Yu-Chieh and Tsai, Shin-Yu and Ho, Hsieh-Hsun},
title = {Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66},
journal = {Nutrients},
year = {2023},
volume = {16},
number = {1},
pages = {126},
doi = {10.3390/nu16010126}
}
EUVIMED